| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3317 | |||||||||||||||||||||||
| Submitter : | Mr. Pedro Najera | Date & Time: | 12/15/2006 08:12:41 | |||||||||||||||||||||
| Organization : | Mr. Pedro Najera | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| This is to request that ethical cell lines be used in vaccine production. | ||||||||||||||||||||||||